Form 4: DocGo Inc. Chief Compliance Officer Reports Stock Transactions
SEC Form 4 Filing
DocGo Inc.'s Chief Compliance Officer, Stephen Sugrue, reported the acquisition of restricted stock units and the withholding of shares for tax obligations.
Summary
- Stephen Sugrue, Chief Compliance Officer of DocGo Inc., reported transactions involving the company's common stock.
- On December 12, 2024, Sugrue was granted 107,399 restricted stock units (RSUs) under the company's 2021 Stock Incentive Plan.
- These RSUs will vest in four equal annual installments starting on December 12, 2025.
- Additionally, Sugrue holds other RSUs that will vest quarterly starting January 1, 2025, and annually starting December 12, 2025.
- On December 13, 2024, 8,734 shares were withheld to cover Sugrue's tax liability related to previously granted RSUs.
- Following these transactions, Sugrue beneficially owns 287,919 shares of DocGo Inc. common stock.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of stock transactions, which is neither positive nor negative in itself. The grant of RSUs is a positive sign of alignment with management, but the tax withholding is a neutral event.
Positives
- The grant of 107,399 RSUs to the Chief Compliance Officer indicates continued alignment of interests between management and shareholders.
- The vesting schedule of the RSUs provides a long-term incentive for the officer.
Negatives
- The withholding of 8,734 shares to cover tax obligations reduces the officer's overall shareholding.
Risks
- The vesting of RSUs is subject to the terms of the 2021 Stock Incentive Plan, which could include performance or continued employment conditions.
- Fluctuations in the stock price could impact the value of the RSUs.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This filing is a routine disclosure of stock transactions by a company officer, which is common practice in publicly traded companies. It reflects the ongoing use of equity-based compensation as part of executive remuneration.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) as a form of compensation is a standard practice among publicly traded companies, particularly in the technology and healthcare sectors.
- The vesting schedules described are typical, with both annual and quarterly vesting periods being common.
- The withholding of shares for tax obligations is also a standard procedure in equity compensation plans.
Stakeholder Impact
- The stock transactions may have a minor impact on the overall shareholding structure of the company.
- The vesting of RSUs could potentially dilute existing shareholders over time.
Next Steps
- The RSUs will continue to vest according to their respective schedules.
- The officer will likely continue to report any further stock transactions.
Key Dates
| Date | Description |
|---|---|
| 12/12/2024 | Grant date of 107,399 restricted stock units (RSUs) and the date of other RSU grants. |
| 12/13/2024 | Date of withholding of 8,734 shares for tax obligations. |
| 12/16/2024 | Date of signature of the Form 4 filing. |
| 12/12/2025 | First vesting date for the 107,399 RSUs granted on December 12, 2024. |
| 01/01/2025 | First vesting date for some of the other RSUs held by the officer. |
Keywords
DocGo, Stock Incentive Plan, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, Stephen Sugrue, Chief Compliance Officer, Stock Transactions, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.